Radiogenomic analysis of prediction HER2 status in breast cancer by linking ultrasound radiomic feature module with biological functions

Table 2 Significance of clinical characteristics in validation cohort

Clinical characteristics	HER2-Positive breast cancer	HER2-Negative breast cancer	p
No. of patients	40	55
Age	50.5 ± 8.1	51.9 ± 9.6	0.394
Lymph nodes			0.132
Positive	4	12
Negative	36	43
T			0.066
T1	8	21
T2	30	32
T3	1	2
T4	1	0
N			0.052
N0	15	32
N1	12	11
N2	10	11
N3	3	1
M			NA
M0	40	55
M1	0	0
TNM stage			0.083
I	6	15
II	20	28
III	14	12
IV	0	0
Menopausal.status			0.134
Menopausal	17	34
Premenopausal	23	21

ISSN: 1479-5876